Development of a tissue array for primary melanoma with long-term follow-up: Discovering melanoma cell adhesion molecule as an important prognostic marker

被引:42
作者
Pacifico, MD [1 ]
Grover, R
Richman, PI
Daley, FM
Buffa, F
Wilson, GD
机构
[1] Mt Vernon Hosp, RAFT Inst Plast Surg, Northwood HA6 2RN, Middx, England
[2] Mt Vernon Hosp, Gray Canc Inst, Northwood HA6 2RN, Middx, England
[3] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA
关键词
D O I
10.1097/01.PRS.0000148417.86768.C9
中图分类号
R61 [外科手术学];
学科分类号
摘要
Refining current prognostic capability is essential for improving the management of melanoma. This study was undertaken to develop a tumor array for the rapid assessment of novel prognostic markers in a series of specimens from melanoma patients with 7- to 10-year follow-up. A melanoma database of 120 patients with archival specimens was created after histopathological review of original specimens. A tissue array was developed allowing 480 biopsy samples from the 120 primary melanoma specimens to be embedded into a single paraffin block. This was sectioned and stained for the adhesion marker melanoma cell adhesion molecule (MCAM); after further review, 76 of the 120 specimens were suitable for further analysis. The slides were assessed by two independent observers without previous knowledge of the clinical outcome for staining positivity and stain intensity. Assessment of association between MCAM and clinicopathological features was carried out using chi-squared analysis, and univariate and Cox multivariate analyses were performed on the data. There was a high correlation between MCAM intensity and both Clark's level and Breslow thickness (Spearman correlation p < 0.001 for both). The data revealed that MACM was a highly specific prognostic marker for survival in univariate analysis (chi(2) = 18, p < 0.0001). Subgroup analysis by stratification of the staining intensity revealed a sequentially worsening survival with increasing staining intensity (chi(2) = 22.33, p < 0.0001). Multivariate analysis of survival showed MCAM to be an independent prognostic marker more accurate than all other clinicopathological parameters (p < 0.0001), including the Breslow depth. Further analysis within only intermediate-thickness tumors showed MCAM intensity added further refinement to outcome prediction (chi(2) = 22.33, p < 0.0001). The tissue array provided a rapid method of analyzing up to 480 specimens within a single paraffin block. This will benefit many areas of plastic surgery research. The identification of adhesion markers revealed a valuable prognostic marker for predicting outcome and a potential target for therapeutic manipulation.
引用
收藏
页码:367 / 375
页数:9
相关论文
共 25 条
  • [1] Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
    Balch, CM
    Soong, SJ
    Gershenwald, JE
    Thompson, JF
    Reintgen, DS
    Cascinelli, N
    Urist, M
    McMasters, KM
    Ross, MI
    Kirkwood, JM
    Atkins, MB
    Thompson, JA
    Coit, DG
    Byrd, D
    Desmond, R
    Zhang, YT
    Liu, PY
    Lyman, GH
    Morabito, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3622 - 3634
  • [2] MODEL PREDICTING SURVIVAL IN STAGE-I MELANOMA BASED ON TUMOR PROGRESSION
    CLARK, WH
    ELDER, DE
    GUERRY, D
    BRAITMAN, LE
    TROCK, BJ
    SCHULTZ, D
    SYNNESTVEDT, M
    HALPERN, AC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24): : 1893 - 1904
  • [3] PROGNOSTIC IMPLICATIONS OF P53 NUCLEAR OVEREXPRESSION AND HIGH PROLIFERATION INDEX OF KI-67 IN ADULT SOFT-TISSUE SARCOMAS
    DROBNJAK, M
    LATRES, E
    POLLACK, D
    KARPEH, M
    DUDAS, M
    WOODRUFF, JM
    BRENNAN, MF
    CORDONCARDO, C
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (07) : 549 - 554
  • [4] Melastatin expression and prognosis in cutaneous malignant melanoma
    Duncan, LM
    Deeds, J
    Cronin, FE
    Donovan, M
    Sober, AJ
    Kauffman, M
    McCarty, JJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 568 - 576
  • [5] Clinico-pathological features of relapsing very thin melanoma
    Fearfield, LA
    Rowe, A
    Francis, N
    Fisher, C
    Gore, ME
    Bunker, CB
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2001, 26 (08) : 686 - 695
  • [6] Heslin MJ, 1998, CANCER-AM CANCER SOC, V83, P490, DOI 10.1002/(SICI)1097-0142(19980801)83:3<490::AID-CNCR18>3.0.CO
  • [7] 2-R
  • [8] Sentinel lymph node biopsy in malignant melanoma: a series of 100 consecutive patients
    Hettiaratchy, SP
    Kang, N
    O'Toole, G
    Allan, R
    Cook, MG
    Powell, BWEM
    [J]. BRITISH JOURNAL OF PLASTIC SURGERY, 2000, 53 (07): : 559 - 562
  • [9] beta 3 integrin expression in melanoma predicts subsequent metastasis
    Hieken, TJ
    Farolan, M
    Ronan, SG
    Shilkaitis, A
    Wild, L
    DasGupta, TK
    [J]. JOURNAL OF SURGICAL RESEARCH, 1996, 63 (01) : 169 - 173
  • [10] E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors
    Hsu, MY
    Meier, FE
    Nesbit, M
    Hsu, JY
    Van Belle, P
    Elder, DE
    Herlyn, M
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (05) : 1515 - 1525